A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.
Over-the-counter (OTC) inhalers are not approved for treating chronic obstructive pulmonary disease (COPD). Aside from the fact that they are ineffective for COPD, these inhalers can pose risks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback